Abstract
Several false positive lo w serum cryptococcal antigen (SCrAg) reports by lateral flow assay (LFA) were identified in late 2016 at our tertiary care hospital. After the recall and correction of the problem in the reagent, we studied the significance of SCrAg LFA ≤1:10 from January 2017 to October 2023. Of 20 patients with 31 samples of SCrAg LFA ≤1:10, 14 patients (70%) were classified as true positives, four (20%) were indeterminate, and only two (10%) patients w ere false positives. If a new SCrA g LFA ≤1:10 is detected, it should be repeated, and additional workup should be pursued.
| Original language | English |
|---|---|
| Article number | myae093 |
| Journal | Medical Mycology |
| Volume | 62 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024 .
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- false positive
- lateral flow assay
- low titer
- serum cryptococcal antigen
ASJC Scopus subject areas
- Infectious Diseases
Fingerprint
Dive into the research topics of 'The significance of low titer serum cryptococcal antigen testing from 2017 to 2023 performed in a tertiary care center'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver